Global Coalition for Adaptive Research

The Global Coalition for Adaptive Research (GCAR) unites physicians, clinical researchers, advocacy and philanthropic organizations, biotech/pharma, health authorities, and other key stakeholders in healthcare to expedite the discovery and development of treatments for patients with rare and deadly diseases. As Sponsor of innovative trials, including master protocols and adaptive platform trials, GCAR is dedicated to the advancement of science by modernizing clinical trials that support more efficient, less costly drug development. Adaptive platform trials deliver an unmatched accelerated time from discovery in the lab to implementation in the clinic resulting in better treatments and lives saved

Adaptive platform trials,glioblastoma gbm,development of cures for patients with rare and deadly diseases,cancer research,cancer policy,clinical trials, cancer treatment,patient information,medical research and development,funding innovative brain cancer research,global research collaboration,fundraising,and advocacy

Global coalition for adaptive research operates in the Research industry.

Global coalition for adaptive research's revenue is 11m - 100m

Global coalition for adaptive research has 11 - 50 employees.